Table 1.
Characteristics of Endometrial Cancer Cases and Controls, 2002-2006, Alberta, Canada
| Characteristics | Cases (n = 519) |
Controls (n = 1,015) |
||
|---|---|---|---|---|
| N | % | N | % | |
| Age at diagnosis/reference date, years | ||||
| < 40 | 11 | 2.1 | 38 | 3.7 |
| 40–49 | 66 | 12.7 | 127 | 12.5 |
| 50–59 | 204 | 39.3 | 376 | 37.1 |
| 60–69 | 170 | 32.8 | 339 | 33.4 |
| 70+ | 68 | 13.1 | 135 | 13.3 |
| Residential status | ||||
| Urban | 349 | 67.2 | 652 | 64.2 |
| Rural | 170 | 32.8 | 363 | 35.8 |
| Education | ||||
| High school diploma or less | 169 | 32.5 | 288 | 28.4 |
| Non-university certificate | 237 | 45.7 | 483 | 47.6 |
| University degree | 113 | 21.8 | 243 | 23.9 |
| Unknown | 0 | 0 | 1 | 0.1 |
| Marital status | ||||
| Never married | 40 | 7.7 | 23 | 2.3 |
| Ever married | 479 | 92.3 | 992 | 97.7 |
| Age at menarche, years of age | ||||
| ≤ 12 | 306 | 59.0 | 508 | 50.1 |
| > 12 | 213 | 41.0 | 507 | 49.9 |
| Oral Contraception | ||||
| Never, < 6 months | 212 | 40.5 | 296 | 29.2 |
| Ever | 305 | 58.2 | 709 | 69.9 |
| 6 – 59 months | 170 | 32.4 | 349 | 34.4 |
| 60+ months | 135 | 25.8 | 359 | 35.4 |
| Unknown duration | 0 | 0 | 1 | 0.1 |
| Unknown hormone type | 7 | 1.3 | 10 | 1.0 |
| Parity | ||||
| 0 | 93 | 17.9 | 105 | 10.3 |
| 1–2 | 225 | 43.4 | 418 | 41.2 |
| 3+ | 201 | 38.7 | 492 | 48.5 |
| BMI, kg/m2 | ||||
| <18.5 | 3 | 0.6 | 9 | 0.9 |
| 18.5–24.9 | 90 | 17.3 | 320 | 31.5 |
| 25–29.9 | 137 | 26.4 | 375 | 37.0 |
| 30+ | 289 | 55.7 | 310 | 30.5 |
| Unknown | 0 | 0 | 1 | 0.1 |
| Smoking status | ||||
| Never | 261 | 50.3 | 520 | 51.2 |
| Former | 196 | 37.8 | 367 | 36.2 |
| Current | 62 | 11.9 | 128 | 12.6 |
| Age at Menopause | ||||
| ≥ 50 | 254 | 63.7 | 436 | 59.6 |
| < 50 | 145 | 36.3 | 296 | 40.4 |
| Menopausal hormone therapya | ||||
| Never use, < 6 months | 235 | 58.9 | 362 | 49.5 |
| Estrogen only | 18 | 4.5 | 23 | 3.1 |
| E+P continuous combined only | 42 | 10.5 | 162 | 22.1 |
| 6 – 59 months | 22 | 5.5 | 61 | 8.3 |
| 60+ months | 20 | 5.0 | 101 | 13.8 |
| Other combinations | 103 | 25.8 | 180 | 24.6 |
| Unknown hormone therapy type | 1 | 0.3 | 5 | 0.7 |
BMI, body mass index; E+P, estrogen plus progesterone; IUD, intra-uterine device
Restricted to post-menopausal women (n=399 cases, n=732 controls).